Tufton Capital Management cut its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 0.9% in the 2nd quarter, Holdings Channel.com reports. The firm owned 28,837 shares of the conglomerate’s stock after selling 275 shares during the quarter. Tufton Capital Management’s holdings in Danaher were worth $5,696,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. NewSquare Capital LLC boosted its holdings in shares of Danaher by 100.5% in the 2nd quarter. NewSquare Capital LLC now owns 425 shares of the conglomerate’s stock valued at $84,000 after buying an additional 213 shares during the last quarter. Prosperity Consulting Group LLC raised its stake in Danaher by 5.1% in the 2nd quarter. Prosperity Consulting Group LLC now owns 1,984 shares of the conglomerate’s stock valued at $392,000 after acquiring an additional 97 shares during the period. Fullcircle Wealth LLC bought a new position in Danaher during the 2nd quarter worth $644,000. Corton Capital Inc. bought a new position in Danaher during the 2nd quarter worth $225,000. Finally, Machina Capital S.A.S. increased its position in shares of Danaher by 56.0% in the second quarter. Machina Capital S.A.S. now owns 22,892 shares of the conglomerate’s stock worth $4,522,000 after purchasing an additional 8,215 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts recently weighed in on DHR shares. JPMorgan Chase & Co. raised their price objective on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Robert W. Baird set a $247.00 price target on Danaher in a research note on Wednesday, October 22nd. Bank of America cut their price target on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, TD Cowen boosted their price objective on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $243.39.
Insider Activity at Danaher
In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by insiders.
Danaher Price Performance
DHR opened at $214.10 on Tuesday. The stock has a 50-day moving average price of $203.53 and a 200-day moving average price of $199.79. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23. The stock has a market capitalization of $151.23 billion, a P/E ratio of 44.14, a PEG ratio of 3.28 and a beta of 0.77.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the business posted $1.71 EPS. The business’s revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- How to Profit From Growth Investing
- Is Starbucks Quietly Setting Up for a Major 2026 Comeback?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- The Best Local Butchers for Thanksgiving [2025 Survey]
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
